secondary metabolism – Page 2

A high-quality genome assembly of angel-wing mushroom Pleurocybella porrigens that causes acute encephalopathy

mycolabadmin

Scientists created a detailed genetic blueprint of the angel-wing mushroom, which caused serious poisonings in Japan. They identified three toxic compounds in the mushroom and found a gene that likely produces one of the most dangerous toxins responsible for brain damage. This research helps explain how the mushroom makes its poison and could lead to better understanding of foodborne illness prevention.

Deletion of bZIP Transcription Factor PratfA Reveals Specialized Metabolites Potentially Regulating Stress Response in Penicillium raistrickii

mycolabadmin

Scientists discovered that a protein called PratfA controls the production of protective compounds in a fungus (Penicillium raistrickii) that help it survive stress. By removing this protein, they found two new natural products, including one with an unusual structure. The fungus without PratfA became very sensitive to oxidative stress and couldn’t survive well, showing that this protein is important for both making protective compounds and surviving harsh conditions.

Integrated Transcriptomics and Metabolomics Provide Insight into Degeneration-Related Molecular Mechanisms of Morchella importuna During Repeated Subculturing

mycolabadmin

Morel mushrooms lose quality when repeatedly cultured in laboratories, becoming slower-growing and less vibrant. Scientists discovered this happens because genes controlling antioxidant production shut down, allowing harmful free radicals to damage cells. By avoiding frequent subculturing and using cold storage or antioxidant supplements, farmers can keep their morel strains healthy and productive for longer.

Quantitative Characterization of Gene Regulatory Circuits Associated With Fungal Secondary Metabolism to Discover Novel Natural Products

mycolabadmin

Scientists developed a special technology using tiny channels and fluorescent markers to understand how fungi control their genes that produce valuable compounds. By precisely measuring how different genes turn on and off in individual fungal cells, they can now predict and control when and how much of useful medicines and other bioactive molecules are made. They successfully used this knowledge to create new pathways that produce novel compounds, including new types of dendrobine molecules never seen before.

Clade III Synthases Add Cyclic and Linear Terpenoids to the Psilocybe Metabolome

mycolabadmin

Researchers identified four enzymes in magic mushrooms that produce various aromatic compounds called terpenes. These findings show that Psilocybe mushrooms make a much wider variety of bioactive molecules beyond just psilocybin. Understanding these additional compounds could help explain why whole mushrooms may have different effects than pure psilocybin alone.

Fruiting body-associated Pseudomonas contact triggers ROS-mediated perylenequinone biosynthesis in Shiraia mycelium culture

mycolabadmin

Scientists discovered that bacteria living inside medicinal mushroom fruiting bodies can trigger the production of powerful healing compounds called perylenequinones through direct physical contact. These compounds are being used to fight cancer and harmful bacteria through a therapy called photodynamic therapy. The study shows that when bacteria touch the mushroom’s cells, it causes the mushroom to produce more of these therapeutic compounds by creating controlled stress that activates specific genes.

Pigment Formation by Monascus pilosus DBM 4361 in Submerged Liquid Culture

mycolabadmin

Scientists studied how to produce natural yellow, orange, and red pigments from the fungus Monascus pilosus in liquid culture. They found that the type of sugar and nitrogen used in the fermentation significantly affects pigment production. Interestingly, glucose actually reduces pigment formation through a process called carbon catabolite repression. M. pilosus offers a safer alternative to other Monascus species because it does not produce the harmful toxin citrinin, making it suitable for use in food products.

Bifunctional Sesquiterpene/Diterpene Synthase Agr2 from Cyclocybe aegerita Gives Rise to the Novel Diterpene Cyclocybene

mycolabadmin

Scientists discovered that a special enzyme from a mushroom called Cyclocybe aegerita can make two different types of aromatic compounds instead of just one. By growing this enzyme in a different mushroom species that provides better raw materials, researchers identified a completely new compound called cyclocybene. This finding shows that using fungi as hosts for producing useful natural chemicals can work better than traditional bacterial systems, potentially opening new paths for making medicines and fragrances.

Differential hypo-osmotic stress responses and regulatory mechanisms of Aspergillus sydowii in amphipod guts and hadal sediments

mycolabadmin

Scientists discovered a new fungus living in the guts of deep-sea amphipods and studied how it survives in extreme pressure and low-salt environments. By comparing this gut fungus with a similar fungus from deep-sea sediments, they found that the gut fungus is better adapted to low-salt conditions and produces different protective chemicals. The study reveals that fungi evolve different survival strategies depending on where they live, using changes in cell walls and energy production to handle environmental stress.

Cloning and Expression Analysis of Phenylalanine Ammonia-Lyase Gene in the Mycelium and Fruit Body of the Edible Mushroom Flammulina velutipes

mycolabadmin

Scientists cloned and studied a gene called PAL in the winter mushroom (Flammulina velutipes), which produces trans-cinnamic acid from phenylalanine. They found that this gene is activated differently depending on the nutrient environment and mushroom developmental stage. The gene is particularly active in the mushroom’s stem during growth, suggesting it helps produce beneficial compounds during mushroom development.

Research Topic: secondary metabolism